AK

Arumugam Kulandhaisamy

Active Director Additional Director DIN 11327847
DIN 11327847 First appointment Oct 2025
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value •••• Premium profile

About Arumugam Kulandhaisamy

Data last updated:

Arumugam Kulandhaisamy is an Additional Director at Dr. Madhan's Ecmo Healthcare Private Limited (since 2025). Dr. Madhan's Ecmo Healthcare Private Limited reported revenue of ₹25,560 (FY 2024).

DIN 11327847
Primary Designation Additional Director
First Appointment 04 Oct 2025
Oldest Company Age 3 yrs
Largest company Dr. Madhan's Ecmo Healthcare Private Limited · ₹25,560 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director04 Oct 20252023₹25,560 (FY 2024)Active

Board colleagues of Arumugam Kulandhaisamy

Directorship timeline

Open interactive timeline →
Dr. Madhan's Ecmo Healthcare Private Limited
Premium access

Shareholding and investment profile for Arumugam Kulandhaisamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arumugam Kulandhaisamy

Arumugam Kulandhaisamy currently holds 1 directorship: Dr. Madhan's Ecmo Healthcare Private Limited (Additional Director, since 04 Oct 2025, revenue ₹25,560 (FY 2024)).

Arumugam Kulandhaisamy was first appointed on 04 Oct 2025 as Additional Director at Dr. Madhan's Ecmo Healthcare Private Limited.

The current boards of Arumugam Kulandhaisamy's companies include Kuzhanthaisami Madhan (Dr. Madhan's Ecmo Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available